Rifabutin absorption in the gut unaltered by concomitant administration of didanosine in AIDS patients.

Didanosine (ddI) is currently used in the management of patients infected by the human immunodeficiency virus. Rifabutin (RBT) is being extensively used for prophylaxis against Mycobacterium avium complex (MAC) infections. Due to its acid-labile characteristics, ddI must be administered with a buffe...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Li, R C, Narang, P K, Sahai, J, Cameron, W, Bianchine, J R
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1997
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163960/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9210686/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.7.1566
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!